ERBB2 and breast carcinoma: In patients with HER2-positive breast cancer undergoing adjuvant hypofractionated left breast radiotherapy concomitantly with anti-HER2 therapy, high-sensitivity cardiac troponin I is being released, dependent on the radiation dose on the heart and its structures.